These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 3306424

  • 1. Therapeutic use of OKT3 monoclonal antibody for acute renal allograft rejection.
    Norman DJ, Shield CF, Barry JM, Henell K, Funnell MB, Lemon J.
    Nephron; 1987; 46 Suppl 1():41-7. PubMed ID: 3306424
    [Abstract] [Full Text] [Related]

  • 2. OKT3 treatment of steroid-resistant renal allograft rejection.
    Thistlethwaite JR, Gaber AO, Haag BW, Aronson AJ, Broelsch CE, Stuart JK, Stuart FP.
    Transplantation; 1987 Feb; 43(2):176-84. PubMed ID: 3544373
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients.
    Leone MR, Barry JM, Alexander SR, Melvin T, Striegel J, Reller K, Henell KR, Kimball J, Funnell MB, Goldstein G.
    J Pediatr; 1990 May; 116(5):S86-91. PubMed ID: 2139465
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Successful retreatment of allograft rejection with OKT3.
    First MR, Schroeder TJ, Hurtubise PE, Mansour ME, Penn I, Munda R, Balistreri WF, Alexander JW, Melvin DB, Fidler JP.
    Transplantation; 1989 Jan; 47(1):88-91. PubMed ID: 2521410
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection.
    Norman DJ, Shield CF, Henell KR, Kimball J, Barry JM, Bennett WM, Leone M.
    Transplantation; 1988 Oct; 46(4):523-9. PubMed ID: 3140448
    [Abstract] [Full Text] [Related]

  • 11. The use of OKT3 in cadaveric renal transplantation for rejection that is unresponsive to conventional anti-rejection therapy.
    Norman DJ, Barry JM, Bennett WM, Leone M, Henell K, Funnell B, Hubert B.
    Am J Kidney Dis; 1988 Feb; 11(2):90-3. PubMed ID: 3124611
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection.
    Waid TH, Lucas BA, Amlot P, Janossy G, Yacoub M, Cammisuli S, Jezek D, Rhoades J, Brown S, Thompson JS.
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):61-70. PubMed ID: 2479265
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody.
    Cosimi AB, Burton RC, Colvin RB, Goldstein G, Delmonico FL, LaQuaglia MP, Tolkoff-Rubin N, Rubin RH, Herrin JT, Russell PS.
    Transplantation; 1981 Dec; 32(6):535-9. PubMed ID: 7041358
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.